Dover has entered into a definitive agreement to accumulate Malema Engineering Corp, a US designer and manufacturer of high-precision, mission-critical flow-measurement and management devices for the biopharmaceutical, semiconductor and industrial sectors.
Malema’s products will increase Dover’s biopharma single-use production offering, which already includes Quattroflow pumps, CPC connectors, and em-tec flowmeters.
Based in Boca Raton, Florida, and with facilities in San Jose, California, Singapore, South Korea and India, Malema expects to generate approximately US$40 million–45 million in income through the full yr 2022.
When the deal closes, Malema will turn into part of the PSG business unit inside Dover’s Pumps & Process Solutions phase.
“ เกจแรงดันน้ำ see an incredible long-term progress opportunity within the bioprocessing business pushed by a powerful and rising pipeline of efficient novel biologic medicine, biosimilars, protein therapies, non-COVID mRNA vaccines, in addition to budding cell & gene therapies,” says PSG’s president Karl Buscher. “Additionally, the growing adoption of extra environment friendly single-use production processes helps a sturdy outlook for our choices of single-use components to end-customers. We believe that pairing Malema’s technology with our current portfolio of single-use pumps for biopharma processing will greatly improve the accuracy and worth proposition of our options to our customers.”
“We are methodically constructing out our biopharma platform by way of proactive capability additions, new product improvement, and opportunistic acquisitions of highly-attractive niche component applied sciences,” said Richard Tobin, president and CEO of Dover. “Malema represents a strategic and highly-complementary flow-control and sensing technology and additional strengthens our sensor portfolio with new proprietary know-how. In addition to engaging biopharma functions, we expect strong growth within the semiconductor area on the capacity enlargement and re-shoring tailwinds.”
Share